Croatia to Decide on Accessibility of Diabetes Drugs Mounjaro and Ozempic

A Croatian HZZO committee is set to decide today whether to include Mounjaro on the list of subsidized medications for type 2 diabetes patients, potentially making it more accessible.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

jutarnji-listBosnian2h ago

Danas odluka hoće li Mounjaro i Ozempic postati dostupniji oboljelima od dijabetesa tipa 2

Danas su na sjednici Povjerenstva HZZO-a za lijekove na dnevnom redu dvije teme važne za velik broj osoba s dijabetesom tipa 2 u Hrvatskoj. Na dnevnom redu je uvrštenje lijeka Mounjaro na listu lijekova uz doplatu za osobe s dijabetesom tipa 2. Mounjaro trenutačno nije dostupan pacijentima preko zdr...

Read full article →

PERSPECTA

PERSPECTA

Croatia to Decide on Accessibility of Diabetes Drugs Mounjaro and Ozempic

Sources

Danas odluka hoće li Mounjaro i Ozempic postati dostupniji oboljelima od dijabetesa tipa 2

Related Stories

PGH Head Nurse Cleared of Fault in P60M Equipment Loss from 2021 Fire

DDB Chief Calls for Stronger Support for Drug Users in the Philippines

Czech Psychiatrist Advocates for Social Media and Mobile Restrictions for Children

Poland to Implement New Sick Leave Regulations in 2026

PERSPECTA